Categorized PT for Non-arthritic Hip and Groin Pain

Sponsor
Hospital for Special Surgery, New York (Other)
Overall Status
Recruiting
CT.gov ID
NCT04720846
Collaborator
(none)
70
1
2
27.9
2.5

Study Details

Study Description

Brief Summary

There is currently limited literature on a categorized physical therapy protocol for management of hip pain. Only a handful of studies have looked at the treatment of osteoarthritis of the hip with a standardized physical therapy treatment, primarily looking at manual therapy versus exercise therapy protocols. However, there are no studies observing the effect of a standardized physical therapy program on patients presenting with non-arthritic hip and groin pain. Based on the gap in the literature, this study will aim to assess the effect of matrix-based standard of care therapy in patients presenting with non-arthritic hip and groin pain.

Condition or Disease Intervention/Treatment Phase
  • Other: Matrix-based physical therapy
  • Other: Standard-of-care physical therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Assessment of a Categorized Physical Therapy Protocol for Non-arthritic Hip and Groin Pain: a Randomized Controlled Study
Actual Study Start Date :
Dec 2, 2020
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

Patients will receive standard-of-care physical therapy.

Other: Standard-of-care physical therapy
Physical therapy that is being conducted as standard-of-care

Experimental: Matrix-Based PT

Patients will receive matrix-based physical therapy, in addition to standard-of-care physical therapy.

Other: Matrix-based physical therapy
Matrix-based physical therapy will be physical therapy that is based on the matrix categorization of the patient (stiff vs. mobile hips, weak vs. strong hips) and involves instructions on the amount of time that should be spent doing stretching and strengthening therapy.

Other: Standard-of-care physical therapy
Physical therapy that is being conducted as standard-of-care

Outcome Measures

Primary Outcome Measures

  1. iHOT-12 (International Hip Outcome Tool-12) [Up to 6 months]

    iHOT-12 is used to assess quality of life in patients with hip disorders. Scores range from 0 to 100; a higher score represents a better quality of life.

Secondary Outcome Measures

  1. NRS (numerical rating scale) pain [Up to 6 months]

    NRS pain will be used to assess pain. Scores range from 0-10, with 10 representing the worst pain imaginable.

  2. Home exercise completion [Up to 6 months]

    This will be defined as the number of times patients completed their home exercises during the previous week.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • New patient presenting with non-arthritic hip impingement, hip pain, and groin pain (Tonnis 0-1)

  • 18-60 years old

Exclusion Criteria:
  • Arthritic hip pain (Tonnis 2+)

  • <18 and >60 years old

  • History of spinal fusion surgery

  • History of low back pain with radicular pain

  • History of hip arthroscopy

  • History of inflammatory conditions, and other concurrent problems interfering with hip therapy (i.e., concurrent back/knee/foot/ankle/shoulder issues)

  • Patients currently taking TNF-alpha inhibitors for inflammatory conditions

  • History of prior knee osteotomy

  • Non-English speakers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital for Special Surgery New York New York United States 10021

Sponsors and Collaborators

  • Hospital for Special Surgery, New York

Investigators

  • Principal Investigator: Peter Moley, MD, Hospital for Special Surgery, New York

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospital for Special Surgery, New York
ClinicalTrials.gov Identifier:
NCT04720846
Other Study ID Numbers:
  • 2019-2120
First Posted:
Jan 22, 2021
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 31, 2022